Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus
US5994106A · kind A · utility
180Cited by
7References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 26, 1996 |
| Grant date | Nov 30, 1999 |
| Priority date | — |
| Expiry date | Nov 26, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/799
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides multiply deficient adenoviral vectors and complementing cell lines. Also provided are recombinants of the multiply deficient adenoviral vectors and a therapeutic method, particularly relating to gene therapy, vaccination, and the like, involving the use of such recombinants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.